zolbetuximab,nivolumab
bms,astellas
[]
#bestofgi23 excellent summary of spotlight trial looking at combination therapy in a target enriched population. what role could #io play? #gi23 #esocsm #gionc. 
#FosterCare alum #GIonc #pallonc #survonc doc @ParkviewHealth.  #supponc #hpm #hapc. ✨#GI23 Featured Voice✨ ASCO FCOI https://t.co/4YWvppctiu